HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Satoshi Suzuki Selected Research

human NPPA protein (carperitide)

1/2022Effect of carperitide on the 1 year prognosis of patients with acute decompensated heart failure.
1/2015Vasopressin V2 receptor antagonist tolvaptan is effective in heart failure patients with reduced left ventricular systolic function and low blood pressure.
1/2014Long-term effects and prognosis in acute heart failure treated with tolvaptan: the AVCMA trial.
12/2013Acute heart failure volume control multicenter randomized (AVCMA) trial: comparison of tolvaptan and carperitide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Satoshi Suzuki Research Topics

Disease

98Neoplasms (Cancer)
12/2022 - 07/2002
53Heart Failure
01/2022 - 02/2007
32Stomach Neoplasms (Stomach Cancer)
03/2022 - 01/2003
24Neoplasm Metastasis (Metastasis)
03/2022 - 08/2004
20Esophageal Neoplasms (Esophageal Cancer)
01/2021 - 09/2006
18Cardiovascular Diseases (Cardiovascular Disease)
08/2018 - 02/2007
15Rectal Neoplasms (Rectal Cancer)
05/2022 - 11/2009
15Carcinoma (Carcinomatosis)
11/2020 - 07/2002
14Inflammation (Inflammations)
10/2021 - 08/2002
14Colorectal Neoplasms (Colorectal Cancer)
10/2019 - 06/2005
12Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2022 - 08/2004
12Death (Near-Death Experience)
07/2020 - 01/2008
11Spinal Cord Diseases
10/2022 - 04/2019
11Pneumonia (Pneumonitis)
08/2021 - 09/2004
11Pulmonary Hypertension
02/2019 - 12/2002
10Pathologic Constriction (Stenosis)
11/2022 - 05/2013
10Chronic Obstructive Pulmonary Disease (COPD)
08/2021 - 07/2009
9Hemorrhage
07/2020 - 10/2010
9Hypoxia (Hypoxemia)
01/2020 - 08/2002
8Lymphatic Metastasis
03/2022 - 08/2004
8Sepsis (Septicemia)
08/2021 - 04/2004
8Paralysis (Palsy)
05/2021 - 12/2016
8Myocardial Infarction
07/2020 - 10/2008
8Infections
01/2020 - 11/2009
8Neonatal Sepsis
12/2012 - 04/2004
7COVID-19
09/2022 - 01/2020
7Disease Progression
09/2022 - 07/2012
7Adenocarcinoma
08/2022 - 07/2005
7Pain (Aches)
12/2021 - 09/2014
7Rheumatoid Arthritis
07/2021 - 02/2005
7Thyroid Neoplasms (Thyroid Cancer)
12/2020 - 06/2015
6Esophageal Squamous Cell Carcinoma
08/2021 - 08/2018
6Chronic Renal Insufficiency
07/2021 - 01/2010
6Wounds and Injuries (Trauma)
11/2020 - 01/2011
6Fibrosis (Cirrhosis)
09/2018 - 01/2012
6Hypertension (High Blood Pressure)
12/2017 - 12/2014
6Heart Arrest (Cardiac Arrest)
04/2016 - 09/2012
6Lung Neoplasms (Lung Cancer)
10/2012 - 11/2006
5Frailty
01/2022 - 01/2018
5Congenital Abnormalities (Deformity)
08/2021 - 01/2017
5Respiratory Insufficiency (Respiratory Failure)
01/2021 - 08/2012
5Body Weight (Weight, Body)
01/2021 - 06/2018
5Liver Diseases (Liver Disease)
09/2020 - 09/2004
5Proteinuria
06/2020 - 06/2003
5Colonic Neoplasms (Colon Cancer)
11/2017 - 02/2013
5Apnea
05/2015 - 10/2009
5Prostatic Neoplasms (Prostate Cancer)
10/2006 - 10/2002
4Squamous Cell Neoplasms (Squamous Cell Cancer)
12/2021 - 02/2016
4Scoliosis
11/2021 - 09/2019
4Kyphosis
10/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
09/2022 - 06/2003
16Biomarkers (Surrogate Marker)IBA
06/2022 - 11/2008
13EnzymesIBA
07/2021 - 11/2003
12C-Reactive ProteinIBA
01/2021 - 01/2008
11Brain Natriuretic Peptide (Natrecor)FDA Link
01/2022 - 02/2007
10Oxygen (Dioxygen)IBA
09/2022 - 06/2003
8Messenger RNA (mRNA)IBA
01/2022 - 05/2005
8AntigensIBA
01/2022 - 10/2002
8Estrogens (Estrogen)FDA Link
07/2013 - 05/2003
6Therapeutic UsesIBA
07/2021 - 10/2002
6tetraethylpyrazine (TEP)IBA
01/2021 - 01/2017
6AlbuminsIBA
09/2020 - 07/2013
6Fluorouracil (Carac)FDA LinkGeneric
08/2019 - 06/2005
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2017 - 11/2006
6Troponin T (Troponin T1)IBA
05/2015 - 03/2007
6Aromatase (CYP19)IBA
07/2013 - 09/2005
5Pharmaceutical PreparationsIBA
01/2022 - 06/2005
5DiureticsIBA
01/2022 - 12/2013
5Anti-Bacterial Agents (Antibiotics)IBA
08/2021 - 03/2011
5DNA (Deoxyribonucleic Acid)IBA
12/2020 - 10/2002
5Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2019 - 12/2002
5salicylhydroxamic acid (SHAM)IBA
09/2018 - 09/2002
5HMGB1 Protein (HMG1)IBA
10/2017 - 10/2008
5CytokinesIBA
01/2017 - 10/2003
5Biological ProductsIBA
01/2017 - 12/2006
5Estrogen ReceptorsIBA
07/2013 - 09/2005
4human NPPA protein (carperitide)IBA
01/2022 - 12/2013

Therapy/Procedure

69Therapeutics
04/2022 - 01/2003
30Esophagectomy
12/2022 - 07/2002
27Gastrectomy
12/2022 - 03/2006
27Lymph Node Excision (Lymph Node Dissection)
01/2022 - 11/2010
25Drug Therapy (Chemotherapy)
03/2022 - 01/2003
15Decompression
11/2022 - 08/2016
13Neoadjuvant Therapy
01/2022 - 07/2013
13Chemoradiotherapy
01/2021 - 08/2011
11Ligation
10/2019 - 08/2005
10Laminectomy
10/2022 - 01/2019
10Patient Readmission
01/2022 - 01/2008
7Operative Time
02/2022 - 09/2015
7Length of Stay
02/2022 - 01/2011
6Proctectomy
05/2022 - 08/2011
6Radiotherapy
01/2021 - 11/2010
5Adjuvant Chemotherapy
02/2022 - 11/2012
5Transplantation
01/2021 - 09/2002
5Immunotherapy
01/2021 - 01/2005
5Aftercare (After-Treatment)
07/2018 - 11/2006
4Laminoplasty
05/2022 - 01/2021
4Palliative Care (Palliative Therapy)
11/2021 - 11/2011
4Spinal Fusion (Spondylosyndesis)
11/2021 - 03/2019
4Activities of Daily Living (ADL)
11/2021 - 03/2013